Ifex 3 g (Ifosfamide POWDER FOR SOLUTION) 3 G

IFEX 3 G is a powder for solution used for intravenous administration. This medication is commonly associated with certain cancer treatments and is manufactured by Baxter Corporation in Canada.

Strength

3 G

Pack Size

60ML

Manufacturer / TM Owner

BAXTER CORPORATION

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

IFEX 3 G, containing the active ingredient ifosfamide, is generally used in the management of specific types of cancer. It is often prescribed as part of a broader treatment plan. Patients may wonder, 'What is IFEX 3 G used for?' Typically, it is utilized in the treatment of various cancers, including but not limited to, sarcomas and lymphomas.

Side Effects

Common effects of IFEX 3 G may include nausea, vomiting, and fatigue. Some patients might experience hair loss or changes in blood cell counts. These effects can vary widely among individuals and should be discussed with a healthcare provider.

Precautions & Warnings

IFEX 3 G should be handled with care, as it is a potent medication. It is important to follow the instructions provided by a healthcare professional regarding administration and storage. Patients should be aware of potential side effects and report any severe or persistent symptoms to their doctor.

Avoid Interactions

IFEX 3 G may interact with other medications, including those that affect the immune system or blood cell production. It is crucial to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and certain supplements may also interact with IFEX 3 G.

Frequently Asked Questions

IFEX 3 G is commonly used in the treatment of certain types of cancer, often as part of a broader treatment plan.

IFEX 3 G is administered intravenously after being reconstituted as a solution.

Common side effects may include nausea, vomiting, fatigue, and hair loss.

IFEX 3 G may interact with other medications, so it is important to consult a healthcare provider before combining it with other treatments.

IFEX 3 G is manufactured by Baxter Corporation in Canada.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.